Critica cuts Jupiter acid use|Cost proof or lab illusion?

The headline is smaller than it looks

Critica’s latest Jupiter result looks like a 30 per cent cost cut. That would be too generous. But it is still important because it moves the story away from the size of the resource and towards the harder question: can the chemistry work at a competitive cost?

Less acid, same strong recoveries

Independent testwork reduced sulphuric acid consumption from a previous reference range of 1.4–1.6 tonnes per tonne of feed to approximately one tonne, under optimised conditions, while maintaining strong rare earth recoveries. Acid is a major input to Jupiter’s proposed hydrometallurgical process, so using less should reduce reagent, transport and handling costs.

The saving happens before chemistry

The detail that matters is where this saving occurs. Earlier beneficiation work reportedly rejected about 95 per cent of the original feed mass, while producing roughly 81 per cent magnet rare earth recovery and a 14-fold upgrade to a concentrate containing about 3 per cent total rare earth oxides. In simple terms, most material could be removed before the expensive chemical stage. The acid reduction makes treatment of that smaller valuable fraction cheaper still.

A large resource is not revenue

That qualifies the intuitive reading of a giant rare-earth resource. Size alone does not create revenue. Critica still has to turn tonnes into a saleable product through a processing route that can be built, supplied and operated consistently. Today’s result strengthens that route, but it does not yet create cash flow or prove the final project economics.

Optimised tests are not a commercial plant

There is also a clear limit to the announcement. The result was achieved under optimised test conditions, not in a commercial plant. The bodies do not establish the project’s capital cost, total operating cost, customer qualification or how the process performs across changing feed grades. The 30 per cent reduction is against an earlier acid-consumption design basis; it is not a 30 per cent reduction in Jupiter’s total cost.

Optimisation continues

So this looks more like a continuing optimisation cycle than a completed structural transformation. The results from ANSTO, GAVAQ and Australian Minmet Metallurgical Laboratories provide useful consistency, but commercial-scale validation remains the central risk.

The scoping study is the test

For a holder, the news is a genuine reduction in processing uncertainty, not permission to book a low-cost mine into the valuation. For a watcher, the important comparison is whether the upcoming scoping study converts the lower acid rate, recovery results and mass rejection into competitive project economics. Critica is targeting that study for the third quarter of 2026, alongside further process optimisation and product qualification.

Chemistry de-risked, business unproven

My reading is that Jupiter has become a more credible processing proposition. The remaining question is whether the laboratory improvement survives variable feed and engineering reality. Until the scoping study answers that, Critica has de-risked the chemistry without yet proving the business.